文献速递系统性红斑狼疮

澳大利亚原住民与托雷斯海峡岛民的系统性红斑狼疮:应对差异与优化患者照护的障碍

Systemic lupus erythematosus in Aboriginal and Torres Strait Islander peoples in Australia: addressing disparities and barriers to optimising patient care.
PubMed 文献 · Lancet Rheumatol · 2024-07-03

本综述总结澳大利亚原住民与托雷斯海峡岛民系统性红斑狼疮(SLE)的发病率、患病率及临床与生物学特征,指出该人群SLE患病风险为一般澳大利亚人群的2至4倍,死亡率高达6倍,狼疮肾炎及进展至终末期肾病的比例更高,并探讨社会经济、环境与生物学因素及医疗照护差异,提出可改善结局的目标。

要点

  • 原住民与托雷斯海峡岛民SLE患病风险为一般澳大利亚人群的2至4倍
  • 该人群SLE死亡率高达一般澳大利亚SLE人群的6倍
  • 狼疮肾炎患病率及进展至终末期肾病比例更高,照护差异限制最佳结局

核心结论

  • 原住民与托雷斯海峡岛民SLE表型独特且严重程度显著增加,死亡率为一般澳大利亚SLE人群的6倍。
  • 该人群狼疮肾炎患病率及进展至终末期肾病比例更高,医疗照护差异限制最佳照护与结局。
  • 患病率与严重程度增加的原因尚不明确,社会经济、环境与生物学因素均可能涉及,但尚无针对该人群SLE的已发表研究,构成重要知识缺口。

研究设计与样本

  • 综述,总结澳大利亚原住民与托雷斯海峡岛民SLE的发病率、患病率及临床与生物学发现的相关数据。

主要发现

  • 原住民与托雷斯海峡岛民SLE患病风险为一般澳大利亚人群的2至4倍。
  • 该人群SLE死亡率高达一般澳大利亚SLE人群的6倍。
  • 该人群狼疮肾炎患病率及进展至终末期肾病比例更高。
  • 患病率与严重程度增加的原因尚不明确,社会经济、环境与生物学因素均可能涉及,但尚无针对该人群SLE的已发表研究。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 尚无针对原住民与托雷斯海峡岛民SLE人群的已发表研究探讨患病率与严重程度增加的原因,构成重要知识缺口。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The first inhabitants of Australia and the traditional owners of Australian lands are the Aboriginal and Torres Strait Islander peoples. Aboriginal and Torres Strait Islander peoples are two to four times more likely to have systemic lupus erythematosus (SLE) than the general Australian population. Phenotypically, SLE appears distinctive in Aboriginal and Torres Strait Islander peoples and its severity is substantially increased, with mortality rates up to six times higher than in the general Australian population with SLE. In particular, Aboriginal and Torres Strait Islander peoples with SLE have increased prevalence of lupus nephritis and increased rates of progression to end-stage kidney disease. The reasons for the increased prevalence and severity of SLE in this population are unclear, but socioeconomic, environmental, and biological factors are all likely to be implicated, although there are no published studies investigating these factors in Aboriginal and Torres Strait Islander peoples with SLE specifically, indicating an important knowledge gap. In this Review, we summarise the data on the incidence, prevalence, and clinical and biological findings relating to SLE in Aboriginal and Torres Strait Islander peoples and explore potential factors contributing to its increased prevalence and severity in this population. Importantly, we identify health disparities and deficiencies in health-care provision that limit optimal care and outcomes for many Aboriginal and Torres Strait Islander peoples with SLE and highlight potentially addressable goals to improve outcomes.

来源:Lancet Rheumatol,查看原文。版权归原作者所有。

引用

  1. Eades LE, Hoi AY, Liddle R, et al. Systemic lupus erythematosus in Aboriginal and Torres Strait Islander peoples in Australia: addressing disparities and barriers to optimising patient care. Lancet Rheumatol. 2024. PMID: 38971169. doi:10.1016/S2665-9913(24)00095-X

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。